CNTG
Centogene NV

996
Loading...
Loading...
News
all
press releases
CENTOGENE Receives Nasdaq Non-Compliance Notice
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 02, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) ( Centogene , we , or the Company ), the essential life science partner for...
Globe Newswire·2y ago
News Placeholder
More News
News Placeholder
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
Longstanding global partnership provides an efficient and timely diagnosis to patients with Lysosomal Storage Disorders (LSDs) CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 19, 2024...
Globe Newswire·2y ago
News Placeholder
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCR Deficiency
Complete Pre-TCR Deficiency Found to be Very Rare, Partial Form More Common Than ExpectedCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq...
Globe Newswire·2y ago
News Placeholder
Centogene receives Nasdaq notice of delisting, will request hearing
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
CENTOGENE Explores Strategic Alternatives
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (the Company ), the essential life science partner for data-driven answers in rare...
Globe Newswire·2y ago
News Placeholder
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company's SecuritiesCAMBRIDGE, Mass. and ROSTOCK, Germanyand BERLIN, Feb. 28, 2024 (GLOBE NEWSWIRE...
Globe Newswire·2y ago
News Placeholder
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
Aims to Leverage Diversified Data to Accelerate and De-Risk Drug Discovery and Clinical DevelopmentCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V...
Globe Newswire·2y ago
News Placeholder
CENTOGENE Receives French Research Tax Credit Accreditation
Partners able to claim up to 30% tax reliefCAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for...
Globe Newswire·2y ago
News Placeholder
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson's Disease Using Multiomics
Collaboration to accelerate research to determine role of GBA geneCAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential...
Globe Newswire·2y ago
News Placeholder
Centogene says FY revenue is expected to be between €48.5 million €49.0 million
Centogene says FY revenue is expected to be between €48.5 million €49.0 million...
SeekingAlpha.com: All News·2y ago

Latest CNTG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.